- Home
- BMRN vs HAS Comparison
BMRN vs HAS Comparison
Compare BMRN & HAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMRN
- HAS
- Stock Information
- Founded
- BMRN 1996
- HAS 1923
- Country
- BMRN United States
- HAS United States
- Employees
- BMRN N/A
- HAS N/A
- Industry
- BMRN Biotechnology: Pharmaceutical Preparations
- HAS Recreational Games/Products/Toys
- Sector
- BMRN Health Care
- HAS Consumer Discretionary
- Exchange
- BMRN Nasdaq
- HAS Nasdaq
- Market Cap
- BMRN 10.0B
- HAS 10.8B
- IPO Year
- BMRN 1999
- HAS N/A
- Fundamental
- Price
- BMRN $51.52
- HAS $76.60
- Analyst Decision
- BMRN Buy
- HAS Strong Buy
- Analyst Count
- BMRN 19
- HAS 10
- Target Price
- BMRN $90.26
- HAS $87.30
- AVG Volume (30 Days)
- BMRN 2.8M
- HAS 2.0M
- Earning Date
- BMRN 10-27-2025
- HAS 10-23-2025
- Dividend Yield
- BMRN N/A
- HAS 3.65%
- EPS Growth
- BMRN 59.53
- HAS N/A
- EPS
- BMRN 2.68
- HAS N/A
- Revenue
- BMRN $3,094,001,000.00
- HAS $4,357,000,000.00
- Revenue This Year
- BMRN $13.32
- HAS $10.39
- Revenue Next Year
- BMRN $7.51
- HAS $6.29
- P/E Ratio
- BMRN $19.20
- HAS N/A
- Revenue Growth
- BMRN 12.39
- HAS 0.79
- 52 Week Low
- BMRN $50.76
- HAS $49.00
- 52 Week High
- BMRN $73.51
- HAS $82.19
- Technical
- Relative Strength Index (RSI)
- BMRN 40.53
- HAS 52.67
- Support Level
- BMRN $51.80
- HAS $74.81
- Resistance Level
- BMRN $53.49
- HAS $78.00
- Average True Range (ATR)
- BMRN 1.84
- HAS 2.33
- MACD
- BMRN -0.08
- HAS 0.07
- Stochastic Oscillator
- BMRN 12.58
- HAS 67.36
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.
About HAS Hasbro Inc.
Hasbro is a branded play company providing children and families around the world with entertainment offerings based on a world-class brand portfolio. From toys and games to television programming, motion pictures, and a licensing program, Hasbro reaches customers by leveraging its well-known brands such as Transformers, Nerf, and Magic: The Gathering. The firm acquired EOne in 2019, bolting on popular family properties like Peppa Pig and PJ Masks, and since has divested noncore lines from the tie-up. Furthermore, the addition of Dungeons & Dragons Beyond in 2022, offers the firm access to 19 million digital tabletop players.